Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 2/20 | 0.73 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.73 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.73 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.73 |
| ▸ | HTR2B | P41595 | 1/20 | 0.73 |
| ▸ | MC3R | P41968 | 1/20 | 0.73 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.73 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.73 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.73 |
| ▸ | TBXA2R | P21731 | 4/20 | 0.57 |
| ▸ | PTGFR | P43088 | 3/20 | 0.57 |
| ▸ | LMNA | P02545 | 3/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | PTGER1 | P34995 | 2/20 | 0.57 |
| ▸ | PTGER3 | P43115 | 2/20 | 0.57 |
| ▸ | SLCO2A1 | Q92959 | 2/20 | 0.57 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.57 |
| ▸ | PTGDR | Q13258 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Unoprostone SCHEMBL18605546 | 1.00 | PGR (0.73) | PGRADORA3SLC6A2ADRA2CHTR2B | |
| Unoprostone SCHEMBL1286326 | 1.00 | PGR (0.73) | PGRADORA3SLC6A2ADRA2CHTR2B | |
| Unoprostone SCHEMBL14957866 | 1.00 | PGR (0.73) | PGRADORA3SLC6A2ADRA2CHTR2B | |
| Unoprostone SCHEMBL2469324 | 1.00 | PGR (0.73) | PGRADORA3SLC6A2ADRA2CHTR2B | |
| SCHEMBL6409055 | 1.00 | PGR (0.73) | PGRADORA3SLC6A2ADRA2CHTR2B | |
| Unoprostone SCHEMBL2469329 | 1.00 | PGR (0.73) | PGRADORA3SLC6A2ADRA2CHTR2B | |
| Unoprostone SCHEMBL1286324 | 1.00 | PGR (0.73) | PGRADORA3SLC6A2ADRA2CHTR2B | |
| SCHEMBL6409062 | 1.00 | PGR (0.73) | PGRADORA3SLC6A2ADRA2CHTR2B | |
| Unoprostone SCHEMBL22965277 | 1.00 | PGR (0.73) | PGRADORA3SLC6A2ADRA2CHTR2B | |
| Unoprostone SCHEMBL572177 | 1.00 | PGR (0.73) | PGRADORA3SLC6A2ADRA2CHTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4200 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4727651-A1 | METHOD OF ENHANCING THE SYSTEMIC HYPOGLYCEMIC EFFECT OF TOPICALLY APPLIED INSULIN WITH THE USE OF PROSTAGLANDIN ANALOGUES: A NOVEL FIXED COMBINATION EYE DROP FORMULATION OF INSULIN AND PROSTAGLANDIN ANALOGUE FOR THE LOWERING OF BLOOD GLUCOSE LEVEL | Gosiengfiao, David Harold (PH) | 2026-04-22 | — | — | EP | claimed |
| EP-4724079-A2 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION | Stealth BioTherapeutics Inc. (US) | 2026-04-15 | — | — | EP | claimed |
| US-12589025-B2 | Intraocular devices, systems, and methods | SIGHT SCIENCES, INC. (US) | 2026-03-31 | — | — | US | claimed |
| US-20260083822-A1 | Topical Ocular Insulin Delivery Enhanced by Prostaglandin Analogues | GOSIENGFIAO DAVID HAROLD (PH) | 2026-03-26 | — | — | US | claimed |
| US-20260048096-A1 | METHODS AND COMPOSITIONS FOR PRESERVING THE RETINAL OUTER NUCLEAR LAYER (ONL), PHOTORECEPTORS, AND RETINAL THICKNESS | STEALTH BIOTHERAPEUTICS INC. (US) | 2026-02-19 | — | — | US | claimed |
| US-12551525-B2 | Collagen peptide-based medicament compositions and devices and methods of production and use thereof | SUSTAIN HOLDINGS, LLC (US) | 2026-02-17 | — | — | US | claimed |
| US-20260034056-A1 | PHARMACEUTICAL COMPOSITIONS FOR TREATING OCULAR DISEASES OR DISORDERS | ALCON INC (CH) | 2026-02-05 | — | — | US | claimed |
| US-20260027105-A1 | COMPOUND MEDICINE COMPOSITION FOR TREATING GLAUCOMA AND USE OF SAME | SHENYANG PHARMACEUTICAL UNIVERSITY (CN) | 2026-01-29 | — | — | US | claimed |
| US-20260000537-A1 | CONTROLLED DRUG DELIVERY OCULAR IMPLANTS AND METHODS OF USING SAME | GLAUKOS CORP (US) | 2026-01-01 | — | — | US | claimed |
| EP-4626373-A2 | BIO-ERODIBLE OCULAR IMPLANTS FOR TREATMENT OF CONDITIONS OF THE EYE | Sight Sciences, Inc. (US) | 2025-10-08 | — | — | EP | claimed |
| CN-1255064-A | Use of 'alpha'-methyl-P-tyrosine to inhibit melanin production in iris melanocytes | PHARMACIA & UPJOHN (SE) | 2000-05-31 | — | — | CN | claimed |
| EP-0998277-A1 | OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION | Merck & Co., Inc. (a New Jersey corp.) (US) | 2000-05-10 | — | — | EP | claimed |
| WO-2000022909-A2 | SYSTEMS FOR ORAL DELIVERY | BIOTECH AUSTRALIA PTY. LIMITED (AU) | 2000-04-27 | — | — | WO | claimed |
| EP-0989972-A1 | PROSTAGLANDIN PHARMACEUTICAL COMPOSITIONS | NICOX S.A. (FR) | 2000-04-05 | — | — | EP | claimed |
| EP-0977575-A1 | THE USE OF $g(a)-METHYL-P-TYROSINE TO INHIBIT MELANIN PRODUCTION IN IRIS MELANOCYTES | Pharmacia & Upjohn AB (SE) | 2000-02-09 | — | — | EP | claimed |
| WO-2000004898-A1 | OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION | MERCK & CO., INC. (US) | 2000-02-03 | — | — | WO | claimed |
| WO-1998058910-A1 | PROSTAGLANDIN PHARMACEUTICAL COMPOSITIONS | NICOX S.A. (FR) | 1998-12-30 | — | — | WO | claimed |
| WO-1998053809-A1 | OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION | MERCK & CO., INC. (US) | 1998-12-03 | — | — | WO | claimed |
| WO-1998047515-A1 | THE USE OF α-METHYL-P-TYROSINE TO INHIBIT MELANIN PRODUCTION IN IRIS MELANOCYTES | PHARMACIA & UPJOHN AB (SE) | 1998-10-29 | — | — | WO | claimed |
| WO-1998022114-A1 | A METHOD FOR PROMOTING TISSUE REPAIR | DUMEX-ALPHARMA A/S (DK) | 1998-05-28 | — | — | WO | claimed |